Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Contact dermatitis - epidemiological study.

Maedica

Statescu L, Branisteanu D, Dobre C, Solovastru LG, Vasilca A, Petrescu Z, Azoicai D.
PMID: 22879841
Maedica (Bucur). 2011 Oct;6(4):277-81.

AIM: To evaluate the real incidence of contact dermatitis, to identify the most common allergens, the favoring factors, to establish the prophylaxis methods, the key for a correct management of the patient with contact dermatitis.METHOD: A retrospective study, on...

Cite
Statescu L, Branisteanu D, Dobre C, et al. Contact dermatitis - epidemiological study. Maedica (Bucur). 2011;6(4):277-81
Statescu, L., Branisteanu, D., Dobre, C., Solovastru, L. G., Vasilca, A., Petrescu, Z., & Azoicai, D. (2011). Contact dermatitis - epidemiological study. Maedica, 6(4), 277-81.
Statescu, Laura, et al. "Contact dermatitis - epidemiological study." Maedica vol. 6,4 (2011): 277-81.
Statescu L, Branisteanu D, Dobre C, Solovastru LG, Vasilca A, Petrescu Z, Azoicai D. Contact dermatitis - epidemiological study. Maedica (Bucur). 2011 Oct;6(4):277-81. PMID: 22879841; PMCID: PMC3391944.
Copy Download .nbib Format: NLM
Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease.

Current health sciences journal

Petrescu F, Petrescu OI, Silosi I, Taisescu C, Petrescu AM, Fortofoiu MC, Enescu A, Enescu AS, Ciobanu D, Biciusca V.
PMID: 30151248
Curr Health Sci J. 2015 Jan-Mar;41(1):35-41. doi: 10.12865/CHSJ.41.01.05. Epub 2015 Mar 15.

Chronic Obstructive Pulmonary Disease (COPD) is a clinical syndrome characterised by a slow progressive decline in expiratory airflow [1], a process that has gradually developed over the years. Studies of patients with COPD show an inflammatory process in the...

Cite
Petrescu F, Petrescu OI, Silosi I, et al. Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease. Curr Health Sci J. 2015;41(1):35-41doi: 10.12865/CHSJ.41.01.05.
Petrescu, F., Petrescu, O. I., Silosi, I., Taisescu, C., Petrescu, A. M., Fortofoiu, M. C., Enescu, A., Enescu, A. S., Ciobanu, D., & Biciusca, V. (2015). Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease. Current health sciences journal, 41(1), 35-41. https://doi.org/10.12865/CHSJ.41.01.05
Petrescu, F, et al. "Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease." Current health sciences journal vol. 41,1 (2015): 35-41. doi: https://doi.org/10.12865/CHSJ.41.01.05
Petrescu F, Petrescu OI, Silosi I, Taisescu C, Petrescu AM, Fortofoiu MC, Enescu A, Enescu AS, Ciobanu D, Biciusca V. Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease. Curr Health Sci J. 2015 Jan-Mar;41(1):35-41. doi: 10.12865/CHSJ.41.01.05. Epub 2015 Mar 15. PMID: 30151248; PMCID: PMC6057535.
Copy Download .nbib Format: NLM
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.

Scientific reports

Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns HJ, Tavazzi L, Maggioni AP, Lip GY.
PMID: 28225014
Sci Rep. 2017 Feb 22;7:42379. doi: 10.1038/srep42379.

No abstract available.

Cite
Boriani G, Laroche C, Diemberger I, et al. Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep. 2017;7:42379doi: 10.1038/srep42379.
Boriani, G., Laroche, C., Diemberger, I., Popescu, M. I., Rasmussen, L. H., Petrescu, L., Crijns, H. J., Tavazzi, L., Maggioni, A. P., & Lip, G. Y. (2017). Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Scientific reports, 742379. https://doi.org/10.1038/srep42379
Boriani, Giuseppe, et al. "Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes." Scientific reports vol. 7 (2017): 42379. doi: https://doi.org/10.1038/srep42379
Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Petrescu L, Crijns HJ, Tavazzi L, Maggioni AP, Lip GY. Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep. 2017 Feb 22;7:42379. doi: 10.1038/srep42379. PMID: 28225014; PMCID: PMC5320510.
Copy Download .nbib Format: NLM
Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania.

Therapeutics and clinical risk management

Bordejevic DA, Pârvănescu T, Petrescu L, Mornoș C, Olariu I, Crișan S, Văcărescu C, Lazăr M, Morariu VI, Citu IM, Tomescu MC, Cozma D.
PMID: 33790565
Ther Clin Risk Manag. 2021 Mar 23;17:249-258. doi: 10.2147/TCRM.S295251. eCollection 2021.

BACKGROUND: Patients with acute myocardial infarction (AMI) are at high risk for left ventricular (LV) remodeling and heart failure. We aimed to study whether LV strains (S) and strain rates (SR) could predict cardiac remodeling in patients with AMI...

Cite
Bordejevic DA, Pârvănescu T, Petrescu L, et al. Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania. Ther Clin Risk Manag. 2021;17:249-258doi: 10.2147/TCRM.S295251.
Bordejevic, D. A., Pârvănescu, T., Petrescu, L., Mornoș, C., Olariu, I., Crișan, S., Văcărescu, C., Lazăr, M., Morariu, V. I., Citu, I. M., Tomescu, M. C., & Cozma, D. (2021). Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania. Therapeutics and clinical risk management, 17249-258. https://doi.org/10.2147/TCRM.S295251
Bordejevic, Diana Aurora, et al. "Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania." Therapeutics and clinical risk management vol. 17 (2021): 249-258. doi: https://doi.org/10.2147/TCRM.S295251
Bordejevic DA, Pârvănescu T, Petrescu L, Mornoș C, Olariu I, Crișan S, Văcărescu C, Lazăr M, Morariu VI, Citu IM, Tomescu MC, Cozma D. Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania. Ther Clin Risk Manag. 2021 Mar 23;17:249-258. doi: 10.2147/TCRM.S295251. eCollection 2021. PMID: 33790565; PMCID: PMC8001577.
Copy Download .nbib Format: NLM
Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets.

Pharmaceutics

Luca CT, Crisan S, Cozma D, Negru A, Lazar MA, Vacarescu C, Trofenciuc M, Rachieru C, Craciun LM, Gaita D, Petrescu L, Mischie A, Iurciuc S.
PMID: 34207606
Pharmaceutics. 2021 Jun 09;13(6). doi: 10.3390/pharmaceutics13060856.

The aim of this paper is to provide an accurate overview regarding the current recommended approach for antihypertensive treatment. The importance of DNA sequencing in understanding the complex implication of genetics in hypertension could represent an important step in...

Cite
Luca CT, Crisan S, Cozma D, et al. Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets. Pharmaceutics. 2021;13(6)doi: 10.3390/pharmaceutics13060856.
Luca, C. T., Crisan, S., Cozma, D., Negru, A., Lazar, M. A., Vacarescu, C., Trofenciuc, M., Rachieru, C., Craciun, L. M., Gaita, D., Petrescu, L., Mischie, A., & Iurciuc, S. (2021). Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets. Pharmaceutics, 13(6), . https://doi.org/10.3390/pharmaceutics13060856
Luca, Constantin-Tudor, et al. "Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets." Pharmaceutics vol. 13,6 (2021). doi: https://doi.org/10.3390/pharmaceutics13060856
Luca CT, Crisan S, Cozma D, Negru A, Lazar MA, Vacarescu C, Trofenciuc M, Rachieru C, Craciun LM, Gaita D, Petrescu L, Mischie A, Iurciuc S. Arterial Hypertension: Individual Therapeutic Approaches-From DNA Sequencing to Gender Differentiation and New Therapeutic Targets. Pharmaceutics. 2021 Jun 09;13(6). doi: 10.3390/pharmaceutics13060856. PMID: 34207606; PMCID: PMC8229802.
Copy Download .nbib Format: NLM
Multifunctional Composite Coatings Based on Photoactive Metal-Oxide Nanopowders (MgO/TiO.

Nanomaterials (Basel, Switzerland)

Fruth V, Todan L, Codrea CI, Poenaru I, Petrescu S, Aricov L, Ciobanu M, Jecu L, Ion RM, Predoana L.
PMID: 34685027
Nanomaterials (Basel). 2021 Sep 30;11(10). doi: 10.3390/nano11102586.

Multifunctional composite coatings composed of metal oxide nanoparticles dispersed in polymer matrices are an advanced solution to solve the problem of stone heritage deterioration. Their innovative design is meant to be stable, durable, transparent, easy to apply and remove,...

Cite
Fruth V, Todan L, Codrea CI, et al. Multifunctional Composite Coatings Based on Photoactive Metal-Oxide Nanopowders (MgO/TiO. Nanomaterials (Basel). 2021;11(10)doi: 10.3390/nano11102586.
Fruth, V., Todan, L., Codrea, C. I., Poenaru, I., Petrescu, S., Aricov, L., Ciobanu, M., Jecu, L., Ion, R. M., & Predoana, L. (2021). Multifunctional Composite Coatings Based on Photoactive Metal-Oxide Nanopowders (MgO/TiO. Nanomaterials (Basel, Switzerland), 11(10), . https://doi.org/10.3390/nano11102586
Fruth, Victor, et al. "Multifunctional Composite Coatings Based on Photoactive Metal-Oxide Nanopowders (MgO/TiO." Nanomaterials (Basel, Switzerland) vol. 11,10 (2021). doi: https://doi.org/10.3390/nano11102586
Fruth V, Todan L, Codrea CI, Poenaru I, Petrescu S, Aricov L, Ciobanu M, Jecu L, Ion RM, Predoana L. Multifunctional Composite Coatings Based on Photoactive Metal-Oxide Nanopowders (MgO/TiO. Nanomaterials (Basel). 2021 Sep 30;11(10). doi: 10.3390/nano11102586. PMID: 34685027; PMCID: PMC8539007.
Copy Download .nbib Format: NLM
Involvement of Oxidative Stress in COPD.

Current health sciences journal

Marginean C, Popescu MS, Vladaia M, Tudorascu D, Pirvu DC, Petrescu F.
PMID: 30622755
Curr Health Sci J. 2018 Jan-Mar;44(1):48-55. doi: 10.12865/CHSJ.44.01.08. Epub 2018 Mar 27.

Chronic obstructive pulmonary disease (COPD) is a disease that affects the lungs and is defined by a variety of symptoms that combined with co-morbidities lead to a decline of the patients quality of life. The principal etiology of chronic...

Cite
Marginean C, Popescu MS, Vladaia M, et al. Involvement of Oxidative Stress in COPD. Curr Health Sci J. 2018;44(1):48-55doi: 10.12865/CHSJ.44.01.08.
Marginean, C., Popescu, M. S., Vladaia, M., Tudorascu, D., Pirvu, D. C., & Petrescu, F. (2018). Involvement of Oxidative Stress in COPD. Current health sciences journal, 44(1), 48-55. https://doi.org/10.12865/CHSJ.44.01.08
Marginean, C, et al. "Involvement of Oxidative Stress in COPD." Current health sciences journal vol. 44,1 (2018): 48-55. doi: https://doi.org/10.12865/CHSJ.44.01.08
Marginean C, Popescu MS, Vladaia M, Tudorascu D, Pirvu DC, Petrescu F. Involvement of Oxidative Stress in COPD. Curr Health Sci J. 2018 Jan-Mar;44(1):48-55. doi: 10.12865/CHSJ.44.01.08. Epub 2018 Mar 27. PMID: 30622755; PMCID: PMC6295184.
Copy Download .nbib Format: NLM
Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort.

TH open : companion journal to thrombosis and haemostasis

Ionescu F, Grasso-Knight G, Castillo E, Naeem E, Petrescu I, Imam Z, Patel VK, Narasimhan M, Nair GB.
PMID: 32995704
TH Open. 2020 Sep 26;4(3):e263-e270. doi: 10.1055/s-0040-1716721. eCollection 2020 Jul.

A hypercoagulable state has been described in coronavirus disease 2019 (COVID-19) patients. Others have reported a survival advantage with prophylactic anticoagulation (pAC) and therapeutic anticoagulation (tAC), but these retrospective analyses have important limitations such as confounding by indication. We...

Cite
Ionescu F, Grasso-Knight G, Castillo E, et al. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH Open. 2020;4(3):e263-e270doi: 10.1055/s-0040-1716721.
Ionescu, F., Grasso-Knight, G., Castillo, E., Naeem, E., Petrescu, I., Imam, Z., Patel, V. K., Narasimhan, M., & Nair, G. B. (2020). Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH open : companion journal to thrombosis and haemostasis, 4(3), e263-e270. https://doi.org/10.1055/s-0040-1716721
Ionescu, Filip, et al. "Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort." TH open : companion journal to thrombosis and haemostasis vol. 4,3 (2020): e263-e270. doi: https://doi.org/10.1055/s-0040-1716721
Ionescu F, Grasso-Knight G, Castillo E, Naeem E, Petrescu I, Imam Z, Patel VK, Narasimhan M, Nair GB. Therapeutic Anticoagulation Delays Death in COVID-19 Patients: Cross-Sectional Analysis of a Prospective Cohort. TH Open. 2020 Sep 26;4(3):e263-e270. doi: 10.1055/s-0040-1716721. eCollection 2020 Jul. PMID: 32995704; PMCID: PMC7519875.
Copy Download .nbib Format: NLM
Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity.

International journal of molecular sciences

Bețiu AM, Chamkha I, Gustafsson E, Meijer E, Avram VF, Åsander Frostner E, Ehinger JK, Petrescu L, Muntean DM, Elmér E.
PMID: 34769217
Int J Mol Sci. 2021 Oct 29;22(21). doi: 10.3390/ijms222111786.

Amiodarone is a potent antiarrhythmic drug and displays substantial liver toxicity in humans. It has previously been demonstrated that amiodarone and its metabolite (desethylamiodarone, DEA) can inhibit mitochondrial function, particularly complexes I (CI) and II (CII) of the electron...

Cite
Bețiu AM, Chamkha I, Gustafsson E, et al. Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity. Int J Mol Sci. 2021;22(21)doi: 10.3390/ijms222111786.
Bețiu, A. M., Chamkha, I., Gustafsson, E., Meijer, E., Avram, V. F., Åsander Frostner, E., Ehinger, J. K., Petrescu, L., Muntean, D. M., & Elmér, E. (2021). Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity. International journal of molecular sciences, 22(21), . https://doi.org/10.3390/ijms222111786
Bețiu, Alina M, et al. "Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity." International journal of molecular sciences vol. 22,21 (2021). doi: https://doi.org/10.3390/ijms222111786
Bețiu AM, Chamkha I, Gustafsson E, Meijer E, Avram VF, Åsander Frostner E, Ehinger JK, Petrescu L, Muntean DM, Elmér E. Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity. Int J Mol Sci. 2021 Oct 29;22(21). doi: 10.3390/ijms222111786. PMID: 34769217; PMCID: PMC8583998.
Copy Download .nbib Format: NLM
[Physiology 2000--retrospect and perspectives].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi

Haulică I, Petrescu G, Slătineanu S.
PMID: 12089916
Rev Med Chir Soc Med Nat Iasi. 2000 Jul-Sep;104(3):15-20.

No abstract available.

Cite
Haulică I, Petrescu G, Slătineanu S. Fiziologia 2000--bilanţ şi perspective. [Physiology 2000--retrospect and perspectives]. Rev Med Chir Soc Med Nat Iasi. 2000;104(3):15-20
Haulică, I., Petrescu, G., & Slătineanu, S. (2000). Fiziologia 2000--bilanţ şi perspective. [Physiology 2000--retrospect and perspectives]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 104(3), 15-20.
Haulică, I, et al. "Fiziologia 2000--bilanţ şi perspective." [Physiology 2000--retrospect and perspectives]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi vol. 104,3 (2000): 15-20.
Haulică I, Petrescu G, Slătineanu S. Fiziologia 2000--bilanţ şi perspective. [Physiology 2000--retrospect and perspectives]. Rev Med Chir Soc Med Nat Iasi. 2000 Jul-Sep;104(3):15-20. Romanian. PMID: 12089916.
Copy Download .nbib Format: NLM
[Considerations on 50 cases of myocardial infarct].

Medicina interna

MIHAIL A, POPESCU P, GHERASIM L, PETRESCU X.
PMID: 13935703
Med Interna (Bucur). 1962 Jun;14:687-91.

No abstract available.

Cite
MIHAIL A, POPESCU P, GHERASIM L, et al. [Considerations on 50 cases of myocardial infarct]. Med Interna (Bucur). 1962;14:687-91
MIHAIL, A., POPESCU, P., GHERASIM, L., & PETRESCU, X. (1962). [Considerations on 50 cases of myocardial infarct]. Medicina interna, 14687-91.
MIHAIL, A, et al. "[Considerations on 50 cases of myocardial infarct]." Medicina interna vol. 14 (1962): 687-91.
MIHAIL A, POPESCU P, GHERASIM L, PETRESCU X. [Considerations on 50 cases of myocardial infarct]. Med Interna (Bucur). 1962 Jun;14:687-91. Romanian. PMID: 13935703.
Copy Download .nbib Format: NLM
[Arterial hypertension of unilateral renal origin].

Probleme de tuberculoza

ENESCU V, OLARU C, PETRESCU M.
PMID: 13389403
Probl Tuberculoza. 1956;3:59-68.

No abstract available.

Cite
ENESCU V, OLARU C, PETRESCU M. Asupra hipertensiunii arteriale de origine renală unilaterală. [Arterial hypertension of unilateral renal origin]. Probl Tuberculoza. 1956;3:59-68
ENESCU, V., OLARU, C., & PETRESCU, M. (1956). Asupra hipertensiunii arteriale de origine renală unilaterală. [Arterial hypertension of unilateral renal origin]. Probleme de tuberculoza, 359-68.
ENESCU, V, et al. "Asupra hipertensiunii arteriale de origine renală unilaterală." [Arterial hypertension of unilateral renal origin]. Probleme de tuberculoza vol. 3 (1956): 59-68.
ENESCU V, OLARU C, PETRESCU M. Asupra hipertensiunii arteriale de origine renală unilaterală. [Arterial hypertension of unilateral renal origin]. Probl Tuberculoza. 1956;3:59-68. Romanian. PMID: 13389403.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries